School-based Program for the Prevention of Rheumatic Heart Disease in Endemic Regions
Recruiting
N/A
Interventional Study
Rheumatic Heart Disease in Children
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 5 – 16
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 6,000 (estimated)
- Sponsor
- Thomas Pilgrim · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The overall objective of the PREVENT trial is to evaluate the effectiveness of an integrated, school-based program for the prevention of rheumatic heart disease (RHD) in regions with an endemic pattern of RHD.
We conduct a stepped wedge cluster randomized trial in randomly selected schools in Nepal and Zambia.
The intervention will be delivered at the level of the school and consists in the intr…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
\- Children aged 5-16 years
Exclusion Criteria:
* Children / primary caregivers not providing informed consent to participate
* Children not attending one of the selected schools
Contacts
Thomas Pilgrim Bern University Hospital, Bern, Switzerland
+41 31 632 08 27
CONTACT